{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T21:17:32Z","timestamp":1773436652727,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/ico.0b013e318268d6f4","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T10:17:45Z","timestamp":1352197065000},"page":"830-834","source":"Crossref","is-referenced-by-count":39,"title":["In Vitro Comparison of Combination and Monotherapy for the Empiric and Optimal Coverage of Bacterial Keratitis Based on Incidence of Infection"],"prefix":"10.1097","volume":"32","author":[{"given":"Regis P.","family":"Kowalski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler A.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M. Q.","family":"Shanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric G.","family":"Romanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Karenchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis S.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210204","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0161-6420(96)30416-8","article-title":". Comparison of ciprofloxacin ophthalmic solution 0.3 to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.","volume":"103","author":"Hyndiuk","year":"1996","journal-title":"Ophthalmology"},{"key":"R4-21-20210204","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s150100050068","article-title":"Comparison of topical 0.3 ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.","volume":"28","author":"Khokhar","year":"2000","journal-title":"Infection"},{"key":"R5-21-20210204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5372\/1905-7415.0501.009","article-title":"The efficacy and safety of 0.5 levofloxacin versus fortified cefazolin and amikacin ophthalmic solution for the treatment of suspected and culture-proven cases of infectious bacterial keratitis: a comparative study.","volume":"5","author":"Kasetsuwan","year":"2011","journal-title":"Asian Biomed"},{"key":"R6-21-20210204","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","article-title":". Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.","volume":"114","author":"Constantinou","year":"2007","journal-title":"Ophthalmology"},{"key":"R7-21-20210204","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajo.2005.08.081","article-title":". Comparison of topical gatifloxacin 0.3 and ciprofloxacin 0.3 for the treatment of bacterial keratitis.","volume":"141","author":"Parmar","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R8-21-20210204","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":". Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R10-21-20210204","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":". Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.","volume":"133","author":"Mather","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R12-21-20210204","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2005.06.025","article-title":". An ophthalmologists guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.","volume":"112","author":"Kowalski","year":"2005","journal-title":"Ophthalmology"},{"key":"R13-21-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-1549(02)00061-5","article-title":"Infectious disease: changing antibiotic susceptibility.","volume":"16","author":"Kowalski","year":"2003","journal-title":"Ophthalmol Clin North Am"},{"key":"R14-21-20210204","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/infdis\/161.6.1170","article-title":"Binding of b-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus.","volume":"161","author":"Chambers","year":"1990","journal-title":"J Infect Dis"},{"key":"R15-21-20210204","first-page":"836","article-title":". Possible usefulness of cephem antibiotics with anti-staphylococcal activity for preventing the spread of methicillin-resistant Staphylococcus aureus.","volume":"46","author":"Hikida","year":"1993","journal-title":"Jpn J Antibiot"},{"key":"R16-21-20210204","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/jsre.1999.5686","article-title":"Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats.","volume":"86","author":"Fallon","year":"1999","journal-title":"J Surg Res"},{"key":"R17-21-20210204","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ajo.2005.01.021","article-title":". The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3) in a NZW rabbit model.","volume":"139","author":"Romanowski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R18-21-20210204","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1473-3099(02)00369-9","article-title":"Fluoroquinolone resistance among Gram-positive cocci.","volume":"2","author":"Hooper","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"R19-21-20210204","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0161-6420(99)00716-2","article-title":"Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.","volume":"106","author":"Goldstein","year":"1999","journal-title":"Ophthalmology"},{"key":"R20-21-20210204","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0161-6420(01)00724-2","article-title":". An in vitro resistance study of levofloxacin, ciprofloxacin and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.","volume":"108","author":"Kowalski","year":"2001","journal-title":"Ophthalmology"},{"key":"R21-21-20210204","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0161-6420(99)00717-4","article-title":"Ciprofloxacin-resistant Pseudomonas keratitis.","volume":"106","author":"Garg","year":"1999","journal-title":"Ophthalmology"},{"key":"R22-21-20210204","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)00196-8","article-title":". Emerging ciprofloxacin-resistant Pseudomonas aeruginosa.","volume":"128","author":"Chaudhry","year":"1999","journal-title":"Am J Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e318268d6f4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:34:26Z","timestamp":1621884866000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201306000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318268d6f4","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}